North America Cardiac Assist Devices Market Outlook to 2036 – Short-Term Circulatory Support Devices, Intra-Aortic Balloon Pumps and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData’s “North America Cardiac Assist Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the North America Cardiac Assist Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Short-Term Circulatory Support Devices, Intra-Aortic Balloon Pumps, Mechanical Circulatory Support Devices and Cardiopulmonary Bypass Equipment

The North America Cardiac Assist Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
• 2025 company share data for Cardiac Assist Devices Market.
• Global corporate-level profiles of key companies operating within the North America Cardiac Assist Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiac Assist Devices is segmented as follows:

• Short-Term Circulatory Support Devices

• Intra-Aortic Balloon Pumps

• Mechanical Circulatory Support Devices

• Cardiopulmonary Bypass Equipment

Reasons to Buy

The North America Cardiac Assist Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

Table of Contents

List of Tables

List of Figures

1 Introduction

1.1 What Is This Report About?

1.2 Cardiac Assist Devices Market Segmentation

1.3 Definitions of Markets Covered in the Report

2 Cardiac Assist Devices Market, North America

2.1 Cardiac Assist Devices Market, North America, Revenue ($m), 2024-2036

2.2 Cardiac Assist Devices Market, North America, Revenue ($m), 2024-2036

2.3 Cardiac Assist Devices Market, North America, Volume (Units), 2024-2036

2.4 Cardiac Assist Devices Market, North America, Volume (Units), 2024-2036

2.5 Cardiac Assist Devices Market, North America, Company Share by Revenue ($m), 2025

3 Cardiac Assist Devices Market, Canada

3.1 Cardiac Assist Devices Market, Canada, Revenue ($m), 2024-2036

3.1.1 Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), by Segment, 2024-2036

3.1.2 Mechanical Circulatory Support Devices Market, Canada, Revenue ($m), by Segment, 2024-2036

3.1.3 Short-Term Circulatory Support Devices Market, Canada, Revenue ($m), by Segment, 2024-2036

3.2 Cardiac Assist Devices Market, Canada, Volume (Units), 2024-2036

3.2.1 Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), by Segment, 2024-2036

3.2.2 Mechanical Circulatory Support Devices Market, Canada, Volume (Units), by Segment, 2024-2036

3.2.3 Short-Term Circulatory Support Devices Market, Canada, Volume (Units), by Segment, 2024-2036

3.3 Cardiac Assist Devices Market, Canada, Average Price ($), 2024-2036

3.4 Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), 2025

4 Cardiac Assist Devices Market, Mexico

4.1 Cardiac Assist Devices Market, Mexico, Revenue ($m), 2024-2036

4.1.1 Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.1.2 Mechanical Circulatory Support Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.1.3 Short-Term Circulatory Support Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.2 Cardiac Assist Devices Market, Mexico, Volume (Units), 2024-2036

4.2.1 Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), by Segment, 2024-2036

4.2.2 Mechanical Circulatory Support Devices Market, Mexico, Volume (Units), by Segment, 2024-2036

4.2.3 Short-Term Circulatory Support Devices Market, Mexico, Volume (Units), by Segment, 2024-2036

4.3 Cardiac Assist Devices Market, Mexico, Average Price ($), 2024-2036

4.4 Cardiac Assist Devices Market, Mexico, Company Share by Revenue ($m), 2025

5 Cardiac Assist Devices Market, United States

5.1 Cardiac Assist Devices Market, United States, Revenue ($m), 2024-2036

5.1.1 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2024-2036

5.1.2 Mechanical Circulatory Support Devices Market, United States, Revenue ($m), by Segment, 2024-2036

5.1.3 Short-Term Circulatory Support Devices Market, United States, Revenue ($m), by Segment, 2024-2036

5.2 Cardiac Assist Devices Market, United States, Volume (Units), 2024-2036

5.2.1 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2024-2036

5.2.2 Mechanical Circulatory Support Devices Market, United States, Volume (Units), by Segment, 2024-2036

5.2.3 Short-Term Circulatory Support Devices Market, United States, Volume (Units), by Segment, 2024-2036

5.3 Cardiac Assist Devices Market, United States, Average Price ($), 2024-2036

5.4 Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), 2025

6 Cardiac Assist Devices Market Pipeline Products

6.1 Cardiac Assist Devices Market Pipeline Products

6.2 Cardiac Assist Devices – Pipeline Products by Stage of Development

6.3 Cardiac Assist Devices – Pipeline Products by Segment

6.4 Cardiac Assist Devices – Pipeline Products by Territory

6.5 Cardiac Assist Devices – Pipeline Products by Regulatory Path

6.6 Cardiac Assist Devices – Pipeline Products by Estimated Approval Date

7 Overview of Key Companies in North America Cardiac Assist Devices Market

7.1 Abiomed Inc

7.1.1 Company Overview

7.2 Abbott Laboratories

7.2.1 Company Overview

7.3 LivaNova Plc

7.3.1 Company Overview

7.4 Getinge AB

7.4.1 Company Overview

7.5 Medtronic Plc

7.5.1 Company Overview

7.6 Teleflex Inc

7.6.1 Company Overview

8 Recent Developments

8.1 Corporate Communications

8.1.1 Nov 24, 2025: Levron Medical Introduces CRPA Technology for Heart Failure Treatment

8.1.2 Nov 24, 2025: CPR Therapeutics Receives U.S. Patent for Advances in Cardioversion and Pacing

8.1.3 Nov 13, 2025: Anthony Campbell Appointed New Harvard Police Chief

8.1.4 Nov 10, 2025: TEDCO Announces Recent Company Formation and Technology Assessment Awardees

8.1.5 Nov 10, 2025: Dr. Felicitas Koller Named Inaugural Hardy-Raju Chair of Transplant Surgery

8.1.6 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth

8.1.7 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms

8.1.8 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

8.1.9 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System

8.1.10 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

8.1.11 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption

8.1.12 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI

8.1.13 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

8.1.14 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing

8.1.15 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study

8.1.16 Oct 23, 2025: Sonus And Providence Health Care Ventures Strengthen Partnership For Clinical Validation Of Wearable Cardiac Ultrasound

8.1.17 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System

8.1.18 Oct 15, 2025: WHO prequalifies two BD Onclarity HPV Assays for automated high-risk HPV detection, including individual genotyping for critical types

8.1.19 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

8.1.20 Oct 11, 2025: Keynote Address by Chair Atkins on Revitalizing Public Company Appeal

8.1.21 Oct 06, 2025: Atacor Medical Secures $75 Million Financing for Pivotal U.S. Study of Extravascular ICD System

8.1.22 Oct 03, 2025: Ventripoint Extends and Upsizes Non-Brokered Convertible Debenture Private Placement

8.1.23 Oct 01, 2025: Cirtec Medical Appoints Steven Chevillotte To Board Of Directors

8.1.24 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts

8.1.25 Sep 29, 2025: Sparrow BioAcoustics Joins Innovators' Network at American Heart Association

8.1.26 Sep 18, 2025: CMS Establishes New DRG 209 For Complex Aortic Arch Procedures

8.1.27 Sep 16, 2025: BioVentrix Appoints Mark H. Ravich as Independent Board Member

8.1.28 Sep 16, 2025: Cirtec Medical Welcomes Chris Cleary to its Board of Directors

8.1.29 Jun 17, 2025: Corvia Medical raises $55m to complete confirmatory heart shunt trial

8.2 Financial Announcements

8.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

8.2.2 Jul 22, 2025: Semler Scientific Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results

8.3 Government and Public Interest

8.3.1 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting

8.3.2 Apr 25, 2025: Delfi Diagnostics To Present Early Detection and Advanced Cancer Monitoring Technology Updates at AACR Annual Meeting

8.4 Legal And Regulatory

8.4.1 Oct 11, 2025: Keynote Address by Chair Atkins on Revitalizing Public Company Appeal

8.4.2 Sep 08, 2025: Shareholders Who Lost Money in Semler Scientific Should Contact Wolf Haldenstein

8.4.3 May 14, 2025: BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders

8.5 Other Significant Developments

8.5.1 Dec 09, 2025: $3.2M NIH Grant to Test and Refine a Heart Pump for Long-Term Use in Children

8.5.2 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months

8.5.3 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

8.5.4 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth

8.5.5 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms

8.5.6 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

8.5.7 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI

8.5.8 Oct 28, 2025: AtriCure Announces First Patient Treated in BoxX-NoAF Clinical Trial

8.5.9 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

8.5.10 Oct 16, 2025: Shape Memory Medical Reaches Midway Milestone in AAA-SHAPE Trial

8.5.11 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting

8.5.12 Sep 22, 2025: HonorHealth Becomes First in Arizona and Southwest to Offer Leadless Cardiac Resynchronization Therapy

8.5.13 Sep 18, 2025: CMS Establishes New DRG 209 For Complex Aortic Arch Procedures

8.6 Product News

8.6.1 Mar 26, 2026: Novel AI-enhanced MRI Boosts Success Rate in Patients with Arrhythmia

8.6.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV

8.6.3 Nov 26, 2025: iCardio.ai Wins Second FDA 510(k) Clearance for CardioVision

8.6.4 Nov 25, 2025: CRISPR Phase 1 Trial Suggests First-of-Its-Kind Heart Treatment

8.6.5 Nov 24, 2025: EchoSolv HF Validation Study Completed at Mayo Clinic

8.6.6 Nov 24, 2025: Levron Medical Introduces CRPA Technology for Heart Failure Treatment

8.6.7 Nov 24, 2025: CPR Therapeutics Receives U.S. Patent for Advances in Cardioversion and Pacing

8.6.8 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results

8.6.9 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared

8.6.10 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months

8.6.11 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States

8.6.12 Nov 13, 2025: EnVVeno Faces FDA Rejection on VenoValve Application

8.6.13 Nov 11, 2025: Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator System in Cardiac Surgeries

8.6.14 Nov 10, 2025: JenaValve's Trilogy System Featured in Live Procedure at TCT 2025

8.6.15 Nov 06, 2025: Agitated Solutions Enrolls First Patient in Phase 3 'Enhance' Trial of Novel Contrast Agent for Cardiac Bubble Studies

8.6.16 Nov 06, 2025: TRiCares Completes First TC-L 55mm Topaz Implant in Ongoing TRICURE EU Pivotal Study

8.6.17 Nov 05, 2025: Fluid Control Solutions For MedTech

8.6.18 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome

8.6.19 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study

8.6.20 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica

8.6.21 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

8.6.22 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System

8.6.23 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

8.6.24 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption

8.6.25 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing

8.6.26 Oct 27, 2025: Successful Patient Outcomes With Edwards’ SAPIEN M3 and EVOQUE Systems

8.6.27 Oct 27, 2025: Dr. Sorajja's Tendyne Device Revolutionizes Heart Valve Replacement

8.6.28 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study

8.6.29 Oct 23, 2025: Ancora Heart Inc. Reports Two-Year Results on AccuCinch System in Heart Failure Patients

8.6.30 Oct 23, 2025: Sonus And Providence Health Care Ventures Strengthen Partnership For Clinical Validation Of Wearable Cardiac Ultrasound

8.6.31 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System

8.6.32 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter

8.6.33 Oct 22, 2025: Norav Medical Launches TeleEVENT – Full Disclosure Event Recorder for Remote Cardiac Telemetry

8.6.34 Oct 19, 2025: MicroPort® HeartLink Catheter Aortic Valve System Launches In Mexico, Achieving Full Coverage In Five Major Latin American Markets

8.6.35 Oct 16, 2025: Shape Memory Medical Reaches Midway Milestone in AAA-SHAPE Trial

8.6.36 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

8.6.37 Oct 09, 2025: Asahi Kasei Achieves FDA Approval for ZOLL’s Zenix Monitor/Defibrillator

8.6.38 Oct 06, 2025: Atacor Medical Secures $75 Million Financing for Pivotal U.S. Study of Extravascular ICD System

8.6.39 Sep 30, 2025: Relief Cardiovascular Announces First-In-Human Procedures With Transcatheter Smart Implant for Heart Failure Treatment

8.6.40 Sep 29, 2025: Sparrow BioAcoustics Joins Innovators' Network at American Heart Association

8.6.41 Sep 29, 2025: iHeartMedia and OSO Studios Launch Cardiac Cowboys Podcast Narrated by Chris Pine

8.6.42 Sep 22, 2025: HonorHealth Becomes First in Arizona and Southwest to Offer Leadless Cardiac Resynchronization Therapy

8.6.43 Sep 21, 2025: IPN Develops AI-Enabled Stethoscope for Heart Damage Detection

8.6.44 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

8.6.45 Sep 18, 2025: CMS Establishes New DRG 209 For Complex Aortic Arch Procedures

8.6.46 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment

8.6.47 Sep 03, 2025: Laza Medical Completes First Human Use of Real-Time AI Heart Model for Cardiac Procedures

8.6.48 Aug 27, 2025: HeartFocus Introduces First Clinical Product in US With Butterfly Network

8.7 Strategy And Business Planning

8.7.1 Feb 09, 2026: Voluntary Announcement Completion of the First Subject Dosing in Phase II Clinical Trial of EDP167

8.7.2 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.

8.7.3 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics

8.7.4 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica

8.7.5 Oct 30, 2025: OrganOx Completes Acquisition By Terumo Corporation

8.7.6 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

8.7.7 Oct 24, 2025: Dechert Advises Shareholders of LARALAB GmbH on Sale to Abbott Laboratories

8.7.8 Oct 23, 2025: Sonus And Providence Health Care Ventures Strengthen Partnership For Clinical Validation Of Wearable Cardiac Ultrasound

8.7.9 Oct 19, 2025: MicroPort® HeartLink Catheter Aortic Valve System Launches In Mexico, Achieving Full Coverage In Five Major Latin American Markets

8.7.10 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider

8.7.11 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

8.7.12 Sep 03, 2025: Laza Medical Completes First Human Use of Real-Time AI Heart Model for Cardiac Procedures

8.7.13 Aug 18, 2025: OneMedNet Announces Long-Term Strategic Partnership With Circle Cardiovascular Imaging

8.7.14 Apr 25, 2025: HeartBeam partners with AccurKardia to enhance cardiac care

9 Appendix

9.1 Research Methodology

9.1.1 Coverage

9.1.2 Secondary Research

9.1.3 Primary Research

9.1.4 Market Modeling and Forecasting

9.1.5 Company Share Analysis

9.1.6 Benchmarking

9.2 GlobalData Consulting

9.3 Contact Us

9.4 Disclaimer

Table

Table 1: Cardiac Assist Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Table 2: Cardiac Assist Devices Market, North America, Revenue ($m), USD Constant, 2024-2036

Table 3: Cardiac Assist Devices Market, North America, Volume (Units), 2024-2036

Table 4: Cardiac Assist Devices Market, North America, Volume (Units), 2024-2036

Table 5: Cardiac Assist Devices Market, North America, Company Share by Revenue ($m), 2025

Table 6: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 7: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 8: Mechanical Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 9: Short-Term Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 10: Cardiac Assist Devices Market, Canada, Volume (Units), 2024-2036

Table 11: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), 2024-2036

Table 12: Mechanical Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036

Table 13: Short-Term Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036

Table 14: Cardiac Assist Devices Market, Canada, Average Price ($), 2024-2036

Table 15: Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025

Table 16: Cardiac Assist Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 17: Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 18: Mechanical Circulatory Support Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 19: Short-Term Circulatory Support Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 20: Cardiac Assist Devices Market, Mexico, Volume (Units), 2024-2036

Table 21: Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), 2024-2036

Table 22: Mechanical Circulatory Support Devices Market, Mexico, Volume (Units), 2024-2036

Table 23: Short-Term Circulatory Support Devices Market, Mexico, Volume (Units), 2024-2036

Table 24: Cardiac Assist Devices Market, Mexico, Average Price ($), 2024-2036

Table 25: Cardiac Assist Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025

Table 26: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 27: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 28: Mechanical Circulatory Support Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 29: Short-Term Circulatory Support Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 30: Cardiac Assist Devices Market, United States, Volume (Units), 2024-2036

Table 31: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2024-2036

Table 32: Mechanical Circulatory Support Devices Market, United States, Volume (Units), 2024-2036

Table 33: Short-Term Circulatory Support Devices Market, United States, Volume (Units), 2024-2036

Table 34: Cardiac Assist Devices Market, United States, Average Price ($), 2024-2036

Table 35: Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025

Table 36: Cardiac Assist Devices Market Pipeline Products

Table 37: Cardiac Assist Devices – Pipeline Products by Stage of Development

Table 38: Cardiac Assist Devices Companies – Pipeline Products by Stage of Development

Table 39: Cardiac Assist Devices – Pipeline Products by Segment

Table 40: Cardiac Assist Devices – Pipeline Products by Territory

Table 41: Cardiac Assist Devices – Pipeline Products by Regulatory Path

Table 42: Cardiac Assist Devices – Pipeline Products by Estimated Approval Date

Table 43: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figures

Figure 1: Cardiac Assist Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Figure 2: Cardiac Assist Devices Market, North America, Revenue ($m), USD Constant, 2024-2036

Figure 3: Cardiac Assist Devices Market, North America, Volume (Units), 2024-2036

Figure 4: Cardiac Assist Devices Market, North America, Volume (Units), 2024-2036

Figure 5: Cardiac Assist Devices Market, North America, Company Share (%), 2025

Figure 6: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 7: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 8: Mechanical Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 9: Short-Term Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 10: Cardiac Assist Devices Market, Canada, Volume (Units), 2024-2036

Figure 11: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), 2024-2036

Figure 12: Mechanical Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036

Figure 13: Short-Term Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036

Figure 14: Cardiac Assist Devices Market, Canada, Company Share (%), 2025

Figure 15: Cardiac Assist Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 16: Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 17: Mechanical Circulatory Support Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 18: Short-Term Circulatory Support Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 19: Cardiac Assist Devices Market, Mexico, Volume (Units), 2024-2036

Figure 20: Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), 2024-2036

Figure 21: Mechanical Circulatory Support Devices Market, Mexico, Volume (Units), 2024-2036

Figure 22: Short-Term Circulatory Support Devices Market, Mexico, Volume (Units), 2024-2036

Figure 23: Cardiac Assist Devices Market, Mexico, Company Share (%), 2025

Figure 24: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 25: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 26: Mechanical Circulatory Support Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 27: Short-Term Circulatory Support Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 28: Cardiac Assist Devices Market, United States, Volume (Units), 2024-2036

Figure 29: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2024-2036

Figure 30: Mechanical Circulatory Support Devices Market, United States, Volume (Units), 2024-2036

Figure 31: Short-Term Circulatory Support Devices Market, United States, Volume (Units), 2024-2036

Figure 32: Cardiac Assist Devices Market, United States, Company Share (%), 2025

Figure 33: Cardiac Assist Devices – Pipeline Products by Stage of Development

Figure 34: Cardiac Assist Devices – Pipeline Products by Segment

Figure 35: Cardiac Assist Devices – Pipeline Products by Territory

Figure 36: Cardiac Assist Devices – Pipeline Products by Regulatory Path

Figure 37: Cardiac Assist Devices – Pipeline Products by Estimated Approval Date

North America Cardiac Assist Devices Market Outlook to 2036 – Short-Term Circulatory Support Devices, Intra-Aortic Balloon Pumps and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

North America Cardiac Assist Devices Market Outlook to 2036 – Short-Term Circulatory Support Devices, Intra-Aortic Balloon Pumps and Others was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Cardiac Assist Devices Market Outlook to 2036 – Short-Term Circulatory Support Devices, Intra-Aortic Balloon Pumps and Others in real time.

  • Access a live North America Cardiac Assist Devices Market Outlook to 2036 – Short-Term Circulatory Support Devices, Intra-Aortic Balloon Pumps and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.